<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>#tech-transfer · Louche Cannon</title>
    <link>https://gbilder.com/tags/tech-transfer/</link>
    <description>#tech-transfer from Louche Cannon</description>
    <language>en</language>
    <lastBuildDate>Sun, 06 Jun 2021 23:17:58 +0200</lastBuildDate>
    <atom:link href="https://gbilder.com/tags/tech-transfer/index.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>Who funded the research behind the Oxford-AstraZeneca COVID-19 vaccine? Approximating the funding to the University of Oxford for the research and development of the ChAdOx vaccine technology | medRxiv</title>
      <link>https://gbilder.com/bookmarks/01M4EHRV5044FJVNPAKGKK0RMA/</link>
      <guid>https://gbilder.com/bookmarks/01M4EHRV5044FJVNPAKGKK0RMA/</guid>
      <pubDate>Sun, 06 Jun 2021 23:17:58 +0200</pubDate>
      <category>patents</category>
      <category>tech-transfer</category>
      <description>&#xA;  &lt;p class=&#34;bafflegab-bookmark&#34;&gt;Bookmarked &lt;a class=&#34;u-bookmark-of&#34; href=&#34;https://www.medrxiv.org/content/10.1101/2021.04.08.21255103v1&#34;&gt;https://www.medrxiv.org/content/10.1101/2021.04.08.21255103v1&lt;/a&gt;&lt;/p&gt;&#xA;  &lt;div class=&#34;e-content&#34;&gt;&lt;p&gt;Our study identified that public funding accounted for 97.1-99.0% of the funding towards the R&amp;amp;D of ChAdOx and the Oxford-AstraZeneca vaccine. We furthermore encountered a severe lack of transparency in research funding reporting mechanisms.&lt;/p&gt;&lt;/div&gt;&#xA;</description>
    </item>
  </channel>
</rss>
